Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 43.09B P/E 62.63 EPS this Y 9.60% Ern Qtrly Grth 10.10%
Income 866.57M Forward P/E 46.77 EPS next Y 13.60% 50D Avg Chg 4.00%
Sales 3.72B PEG 3.60 EPS past 5Y 17.05% 200D Avg Chg 12.00%
Dividend N/A Price/Book 39.42 EPS next 5Y 12.00% 52W High Chg -8.00%
Recommedations 2.20 Quick Ratio 1.02 Shares Outstanding 82.59M 52W Low Chg 64.00%
Insider Own 0.93% ROA 22.63% Shares Float 81.68M Beta 1.26
Inst Own 92.63% ROE 71.91% Shares Shorted/Prior 1.71M/1.80M Price 519.18
Gross Margin 60.14% Profit Margin 23.26% Avg. Volume 454,379 Target Price 578.84
Oper. Margin 31.01% Earnings Date Jul 30 Volume 759,719 Change -2.46%
About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDEXX Laboratories, Inc. News
05/04/24 23 Most Profitable Stocks of the Last 12 Months
05/03/24 IDEXX Laboratories, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
05/02/24 IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
05/02/24 IDEXX Laboratories First Quarter 2024 Earnings: EPS Beats Expectations
05/02/24 IDEXX Laboratories Inc (IDXX) (Q1 2024) Earnings Call Transcript Highlights: Key Financial ...
05/01/24 Q1 2024 IDEXX Laboratories Inc Earnings Call
05/01/24 Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
05/01/24 IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
05/01/24 Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
05/01/24 IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
05/01/24 IDEXX Laboratories Inc (IDXX) Q1 Earnings: Exceeds Revenue Estimates, EPS Surpasses Expectations
05/01/24 Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates
05/01/24 IDEXX Laboratories Announces First Quarter Results
04/28/24 11 Oversold Growth Stocks to Buy Right Now
04/26/24 Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
04/25/24 Veeva's (VEEV) AI Partner Program to Develop GenAI Solutions
04/25/24 Integer (ITGR) Q1 Earnings and Revenues Top Estimates
04/24/24 Eaton Vance Worldwide Health Sciences Fund Bolsters Position in IDEXX Laboratories
04/24/24 Penumbra's (PEN) New Launch to Enhance Blood Clot Removal
04/20/24 IDEXX Laboratories Insiders Sell US$4.5m Of Stock, Possibly Signalling Caution
IDXX Chatroom

User Image Wisenheimer Posted - 1 day ago

$ZOM hasn’t even reached the levels of the $IDXX buyer

User Image IN0V8 Posted - 5 days ago

$IDXX Barclays cuts target price to $570 from $655 Stifel cuts target price to $520 from $570

User Image Figaroke Posted - 1 week ago

$IDXX Guidance got cut. Albeit it is a small adjustment, this will most likely drop significantly given the extremely high valuation

User Image epsguid Posted - 1 week ago

$IDXX reported earnings of $2.81, consensus was $2.68, Earnings Whisper was $2.75 via @eWhispers #whisperbeat http://eps.sh/d/idxx

User Image Estimize Posted - 1 week ago

$IDXX beats the Estimize EPS Consensus by 1c and misses the Estimize Revenue Consensus by $9.26M. Reports FQ1 earnings of $2.81 EPS and... http://www.estimize.com/idxx/fq1-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 1 week ago

$IDXX Idexx Laboratories cuts FY24 EPS view to $10.82-$11.20 from $10.84-$11.33 FY24 consensus $11.12. Cuts FY24 revenue view to $3.895B-$3.965B from $3.93B-$4.04B, consensus $3.99B.

User Image DonCorleone77 Posted - 1 week ago

$IDXX Idexx Laboratories reports Q1 EPS $2.81, consensus $2.67 Reports Q1 revenue $964M, consensus $966.13M. "High levels of execution from IDEXX teams drove strong results in the first quarter. This performance reflects continued high interest from customers in adopting IDEXX's innovative, multi-modality testing platforms and solutions," said Jay Mazelsky, President and Chief Executive Officer. "By partnering with IDEXX, veterinarians use the differentiated diagnostics insights generated by IDEXX solutions to deliver better patient outcomes, while also driving better business results through workflow optimization and staff productivity."

User Image Stock_Titan Posted - 1 week ago

$IDXX IDEXX Laboratories Announces First Quarter Results https://www.stocktitan.net/news/IDXX/idexx-laboratories-announces-first-quarter-mkk34wpp6a2t.html

User Image Estimize Posted - 04/30/24

$IDXX reports before the open tomorrow, Estimize Consensus +0.09 EPS and +9.32M Revs compared to WS http://www.estimize.com/idxx/fq1-2024?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image King_of_the_Trade Posted - 04/30/24

$IVP actually... Got 3 cute little kittens scratching at my ankles every day as I sit at my desk.🐈 😀 What I hate is horrible, incompetent management @ #thePartners. They'll see this company in the ground sooner than later. Expect a rewashing of offerings and bleed before OTC entrance. Only hope this company has is to be acquired by a more structured company... one with stability (coughs... "$IDXX") 😗 The partners at IVP, on their own, couldn't manage to open and see the completed cook of a box of do-it-yourself Idahoan mashed potatoes! As a owner here, I take no joy in this fact. But what can't be done is blind pom pom shaking just because I own it. 🤣 #YourKing is here!

User Image Davdesam Posted - 1 month ago

$IDXX $IVP probably not

User Image cb28 Posted - 1 month ago

$IVP $IDXX shit i hope it's true lol

User Image D_ANDRE Posted - 1 month ago

$IVP $IDXX I highly doubt it. Didn't this whole thing started from this comment on Yahoo IVP forum? It's absolutely hilarious that some people on here are discussing and theorizing as if there's any truth to this. I mean, for crying out loud, the commenter is pretending to be Kimball Carr!

User Image Kpick Posted - 1 month ago

$IDXX any truth to these guys buying $IVP ?

User Image cb28 Posted - 1 month ago

$IDXX $IVP based on?

User Image Spermwhale Posted - 1 month ago

$IDXX Could they be buying $IVP ????

User Image Stock_Titan Posted - 1 month ago

$IDXX IDEXX Laboratories to Release 2024 First Quarter Financial Results https://www.stocktitan.net/news/IDXX/idexx-laboratories-to-release-2024-first-quarter-financial-g8i14ejxxldh.html

User Image StockInvest_us Posted - 1 month ago

Signal alert: $IDXX - Oversold Trend Short (Undervalued) https://stockinvest.us/l/2BTcPrI189

User Image StockInvest_us Posted - 1 month ago

Signal alert: $IDXX - PivotPoint bottom https://stockinvest.us/l/d0Cft7ZkeN

User Image lucy2134 Posted - 03/26/24

$CHWY I hope they buy idexx $IDXx

User Image StockInvest_us Posted - 03/22/24

Signal alert: $IDXX - Oversold Trend Short (Undervalued) https://stockinvest.us/l/5Snh5QRIOT

User Image Nosh Posted - 03/18/24

$IDXX $SMCI May give new starter entry points again...

User Image AnchorsAweigh Posted - 03/18/24

$IDXX shake and bake potential

User Image Laynester Posted - 03/15/24

$IDXX $ZTS $MLAB $APPL We love short shorts - on our short list today. We are profiting on all as of 3/15/2024 8:58am EST. Set a 7% trlr buy; if the long term weekly chart shows a change in price direction (e.g. $AAPL) set a 3.5% trlr buy and let it ride out or wait for a further direction down and reset 7% - 3.5% routine outlined above. You got this!

User Image AnchorsAweigh Posted - 2 months ago

$IDXX shake during the week and show the flop on a Friday

User Image Thelonius_Stonk Posted - 2 months ago

$IDXX preparing for liftoff 🤞

User Image JFDI Posted - 2 months ago

$IDXX go time or go time.

User Image Thelonius_Stonk Posted - 2 months ago

$IDXX short term hidden bullish divergence, need a bounce

User Image Thelonius_Stonk Posted - 2 months ago

$IDXX potential too move up quickly out of this structure

User Image AnchorsAweigh Posted - 2 months ago

$IDXX a fav for next week

Analyst Ratings
Barclays Overweight May 2, 24
JP Morgan Overweight Feb 6, 24
Barclays Overweight Feb 6, 24
Piper Sandler Neutral Jan 30, 24
Goldman Sachs Buy Jan 17, 24
Piper Sandler Overweight Nov 6, 23
Goldman Sachs Buy Nov 3, 23
JP Morgan Overweight Nov 2, 23
Barclays Overweight Nov 2, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
POLEWACZYK JAMES F Executive Vice Presi.. Executive Vice President Dec 07 Sell 521.77 11,636 6,071,316 10,050 12/08/23
POLEWACZYK JAMES F Executive Vice Presi.. Executive Vice President Dec 07 Option 247.86 11,636 2,884,099 21,686 12/08/23
MAZELSKY JONATHAN JAY President and CEO President and CEO Dec 04 Sell 513.23 7,128 3,658,303 79,233 12/06/23
MAZELSKY JONATHAN JAY President and CEO President and CEO Dec 04 Option 79.54 13,424 1,067,745 86,361 12/06/23
Lane Michael Executive Vice Presi.. Executive Vice President Nov 07 Option 129.24 1,728 223,327 5,774 11/08/23
MAZELSKY JONATHAN JAY President and CEO President and CEO Aug 31 Sell 512.01 13,424 6,873,222 72,925 09/05/23
MAZELSKY JONATHAN JAY President and CEO President and CEO Aug 31 Option 79.54 13,424 1,067,745 86,349 09/05/23
POLEWACZYK JAMES F Executive Vice Presi.. Executive Vice President Aug 29 Sell 510.23 22,909 11,688,859 10,038 08/31/23
POLEWACZYK JAMES F Executive Vice Presi.. Executive Vice President Aug 29 Option 141.69 16,909 2,395,836 32,947 08/31/23
Lane Michael Executive Vice Presi.. Executive Vice President Aug 03 Sell 510 16,027 8,173,770 4,034 08/07/23
Lane Michael Executive Vice Presi.. Executive Vice President Aug 03 Option 175.6 16,027 2,814,341 20,061 08/07/23
AYERS JONATHAN W Director Director May 18 Option 79.54 20,000 1,590,800 147,039 05/22/23
AYERS JONATHAN W Director Director May 18 Sell 491.23 20,000 9,824,600 137,039 05/22/23
AYERS JONATHAN W Director Director May 09 Option 178.26 560 99,826 141,894 05/11/23
Underberg Sharon E. EVP, GC & Corporate.. EVP, GC & Corporate Secretary May 05 Option 206.94 483 99,952 4,245 05/08/23
SZOSTAK M ANNE Director Director May 05 Sell 474.99 2,000 949,980 4,700 05/08/23
MCKEON BRIAN P EVP, CFO and Treasur.. EVP, CFO and Treasurer May 05 Option 178.26 560 99,826 29,605 05/08/23
Vandebroek Sophie V. Director Director May 04 Sell 469.02 2,187 1,025,747 872 05/05/23
Vandebroek Sophie V. Director Director May 04 Option 206.62 2,187 451,878 3,059 05/05/23
MAZELSKY JONATHAN JAY President and CEO President and CEO May 04 Option 178.26 560 99,826 73,301 05/05/23
Turner Kathy V Senior Vice Presiden.. Senior Vice President Feb 14 Sell 504.16 2,000 1,008,320 7,380 02/16/23
Turner Kathy V Senior Vice Presiden.. Senior Vice President Feb 14 Option 13.26 2,732 36,226 9,380 02/16/23
SZOSTAK M ANNE Director Director Dec 02 Option 160.28 2,000 320,560 2,000 12/06/22
SZOSTAK M ANNE Director Director Dec 02 Sell 428.55 740 317,127 1,260 12/06/22
MAZELSKY JONATHAN JAY President & CEO President & CEO Nov 14 Sell 434.65 10,500 4,563,825 70,805 11/16/22
MAZELSKY JONATHAN JAY President & CEO President & CEO Nov 14 Option 62 18,998 1,177,876 81,305 11/16/22
Turner Kathy V Senior Vice Presiden.. Senior Vice President Nov 10 Option 192.6 13,877 2,672,710 15,490 11/14/22
Turner Kathy V Senior Vice Presiden.. Senior Vice President Nov 10 Sell 422.91 13,877 5,868,722 6,923 11/14/22
MAZELSKY JONATHAN JAY President & CEO President & CEO Nov 07 Option 52 24,002 1,248,104 75,537 11/09/22
MAZELSKY JONATHAN JAY President & CEO President & CEO Nov 07 Sell 382.07 13,230 5,054,786 62,307 11/09/22
Underberg Sharon E. EVP, GC & Corp. Secr.. EVP, GC & Corp. Secretary Feb 17 Option 206.94 483 99,952 2,987 02/18/22
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Feb 16 Option 141.60 706 99,970 28,154 02/17/22
AYERS JONATHAN W Director Director Feb 15 Sell 509.7 250 127,425 629,490 02/17/22
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Nov 08 Option 67.85 16,310 1,106,634 32,627 11/10/21
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Nov 08 Sell 629.21 16,310 10,262,415 26,317 11/10/21
Turner Kathy V Senior Vice Presiden.. Senior Vice President May 26 Sell 547 2,900 1,586,300 4,866 05/26/21
AYERS JONATHAN W Director Director May 20 Option 79.54 7,632 607,049 661,333 05/20/21
AYERS JONATHAN W Director Director May 12 Sell 541.74 512 277,371 653,701 05/12/21
HENDERSON REBECCA M Director Director Feb 25 Option 160.28 3,046 488,213 17,742 02/25/21
HENDERSON REBECCA M Director Director Feb 25 Sell 513.41 3,046 1,563,847 14,696 02/25/21
Claflin Bruce L. Director Director Feb 18 Option 122.64 7,027 861,791 7,331 02/18/21
Claflin Bruce L. Director Director Feb 18 Sell 537.04 7,331 3,937,040 02/18/21
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Feb 17 Option 0 2,642 27,356 02/17/21
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Feb 17 Sell 539.58 1,307 705,231 24,714 02/17/21
Lane Michael Executive Vice Presi.. Executive Vice President Feb 17 Option 0 984 4,768 02/17/21
Lane Michael Executive Vice Presi.. Executive Vice President Feb 17 Sell 545 850 463,250 3,624 02/17/21
Vandebroek Sophie V. Director Director Feb 16 Option 160.28 3,046 488,213 6,367 02/16/21
Vandebroek Sophie V. Director Director Feb 16 Sell 538.2 3,046 1,639,357 3,321 02/16/21
MCKEON BRIAN P Executive VP & CFO Executive VP & CFO Nov 10 Sell 475.43 10,000 4,754,300 18,050 11/10/20
MAZELSKY JONATHAN JAY President & CEO President & CEO Nov 09 Option 70.77 2,868 202,968 41,413 11/09/20